Wilson disease complicated by Crohn disease: A case report and literature review

被引:0
作者
Chen, Minmin [1 ]
Li, Chenyan [2 ]
Peng, Shiqiao [2 ]
Liu, Mengyuan [3 ]
Li, Yiling [1 ]
Sun, Mingjun [1 ,3 ]
Sun, Xuren [1 ,4 ]
机构
[1] China Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Shenyang, Peoples R China
[2] China Med Univ, Affiliated Hosp 1, Dept Endocrinol & Metab, Shenyang, Peoples R China
[3] China Med Univ, Affiliated Hosp 1, Dept Gastrointestinal Endoscopy, Shenyang, Peoples R China
[4] China Med Univ, Affiliated Hosp 1, Dept Gastroenterol, North Nanjing St 155, Shenyang 110001, Peoples R China
关键词
Crohn disease; hepatolenticular degeneration; inflammatory bowel disease; ustekinumab; Wilson disease; INFLAMMATORY-BOWEL-DISEASE; ULCERATIVE-COLITIS; CERULOPLASMIN; COPPER; ASSOCIATION; USTEKINUMAB; METABOLISM;
D O I
10.1097/MD.0000000000033839
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Rational:Wilson disease (WD), also known as hepatolenticular degeneration, is an autosomal-recessive hereditary disease with abnormal copper metabolism. Crohn disease (CD) is a chronic inflammatory gastrointestinal disease, which belongs to inflammatory bowel disease, all segments of the gastrointestinal tract can be affected, especially the terminal ileum and colon, accompanied by extraintestinal manifestations and related immune disorders. WD complicated by ulcerative colitis has been reported before, but WD complicated by CD has not been reported so far. Patient concerns and diagnosis:We presented the first report of a young patient with WD complicated by CD, who was admitted to the hospital because of repeated low fever, elevated C-reactive protein for 3 years, and anal fistula for 6 months. Interventions and outcomes:In this complicated disease, Ustekinumab is safe and effective. Lessons:We conclude that copper metabolism and oxidative stress play important roles in WD and CD.
引用
收藏
页数:4
相关论文
共 30 条
  • [1] Clinical Trials of IL-12/IL-23 Inhibitors in Inflammatory Bowel Disease
    Almradi, Ahmed
    Hanzel, Jurij
    Sedano, Rocio
    Parker, Claire E.
    Feagan, Brian G.
    Ma, Christopher
    Jairath, Vipul
    [J]. BIODRUGS, 2020, 34 (06) : 713 - 721
  • [2] Concepts of oxidative stress and antioxidant defense in Crohn's disease
    Alzoghaibi, Mohammed A.
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2013, 19 (39) : 6540 - 6547
  • [3] Protective role of macrophage-derived ceruloplasmin in inflammatory bowel disease
    Bakhautdin, Bakytzhan
    Febbraio, Maria
    Goksoy, Esen
    de la Motte, Carol A.
    Gulen, Muhammet F.
    Childers, Erin Patricia
    Hazen, Stanley L.
    Li, Xiaoxia
    Fox, Paul L.
    [J]. GUT, 2013, 62 (02) : 209 - 219
  • [4] Ustekinumab in Pediatric Crohn Disease Patients
    Bishop, Casey
    Simon, Hayley
    Suskind, David
    Lee, Dale
    Wahbeh, Ghassan
    [J]. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2016, 63 (03) : 348 - 351
  • [5] Ceruloplasmin Is an Endogenous Inhibitor of Myeloperoxidase
    Chapman, Anna L. P.
    Mocatta, Tessa J.
    Shiva, Sruti
    Seidel, Antonia
    Chen, Brian
    Khalilova, Irada
    Paumann-Page, Martina E.
    Jameson, Guy N. L.
    Winterbourn, Christine C.
    Kettle, Anthony J.
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2013, 288 (09) : 6465 - 6477
  • [6] Wilson disease
    Czlonkowska, Anna
    Litwin, Tomasz
    Dusek, Petr
    Ferenci, Peter
    Lutsenko, Svetlana
    Medici, Valentina
    Rybakowski, Janusz K.
    Weiss, Karl Heinz
    Schilsky, Michael L.
    [J]. NATURE REVIEWS DISEASE PRIMERS, 2018, 4
  • [7] Real World Experience With Ustekinumab in Children and Young Adults at a Tertiary Care Pediatric Inflammatory Bowel Disease Center
    Dayan, Judy R.
    Dolinger, Michael
    Benkov, Keith
    Dunkin, David
    Jossen, Jacqueline
    Lai, Joanne
    Phan, Becky L.
    Pittman, Nanci
    Dubinsky, Marla C.
    [J]. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2019, 69 (01) : 61 - 67
  • [8] A comprehensive review and update on Crohn's disease
    Gajendran, Mahesh
    Loganathan, Priyadarshini
    Catinella, Anthony P.
    Hashash, Jana G.
    [J]. DM DISEASE-A-MONTH, 2018, 64 (02): : 20 - 57
  • [9] Ceruloplasmin metabolism and function
    Hellman, NE
    Gitlin, JD
    [J]. ANNUAL REVIEW OF NUTRITION, 2002, 22 : 439 - 458
  • [10] Serum copper, ceruloplasmin and 24-h urine copper evaluations in celiac patients
    Ince, Ali Tuezuen
    Kayadibi, Hueseyin
    Soylu, Aliye
    Ovunc, Oya
    Gultepe, Mustafa
    Toros, Alunet Burak
    Yasar, Buelent
    Kendir, Tulin
    Abut, Evren
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2008, 53 (06) : 1564 - 1572